首页 > 最新文献

Im Fokus Onkologie最新文献

英文 中文
Die meisten Patienten mit Krebsdiagnose trinken Alkohol 大多数确诊癌症的患者都饮酒
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3710-4
Robert Bublak
{"title":"Die meisten Patienten mit Krebsdiagnose trinken Alkohol","authors":"Robert Bublak","doi":"10.1007/s15015-023-3710-4","DOIUrl":"https://doi.org/10.1007/s15015-023-3710-4","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"33 20","pages":"39"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139686432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmazeutische Betreuung in der Onkologie 肿瘤药物治疗
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3739-z
K. Bornemann
{"title":"Pharmazeutische Betreuung in der Onkologie","authors":"K. Bornemann","doi":"10.1007/s15015-024-3739-z","DOIUrl":"https://doi.org/10.1007/s15015-024-3739-z","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"88 6","pages":"24-27"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PD-1-Hemmer verlängert Leben bei Nasopharynxkarzinom PD-1抑制剂可延长鼻咽癌患者的寿命
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3753-1
T. Müller
{"title":"PD-1-Hemmer verlängert Leben bei Nasopharynxkarzinom","authors":"T. Müller","doi":"10.1007/s15015-024-3753-1","DOIUrl":"https://doi.org/10.1007/s15015-024-3753-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"58 3","pages":"55"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687681","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mammakarzinom: Lebensqualität bleibt unter T-DXd erhalten 乳腺癌：使用 T-DXd 可保持生活质量
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3702-4
J. Neumaier
{"title":"Mammakarzinom: Lebensqualität bleibt unter T-DXd erhalten","authors":"J. Neumaier","doi":"10.1007/s15015-023-3702-4","DOIUrl":"https://doi.org/10.1007/s15015-023-3702-4","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"32 2","pages":"28"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139685104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ovarial-Ca.: PARP-Hemmer auch bei R0-Resektion vorteilhaft 卵巢癌：PARP 抑制剂也有利于 R0 切除术
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3720-2
T. Müller
{"title":"Ovarial-Ca.: PARP-Hemmer auch bei R0-Resektion vorteilhaft","authors":"T. Müller","doi":"10.1007/s15015-023-3720-2","DOIUrl":"https://doi.org/10.1007/s15015-023-3720-2","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"50 6","pages":"29"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139686379","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitoren von Histondeacetylasen 组织乙酰抑制剂
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3737-1
Sabrina Kempe
{"title":"Inhibitoren von Histondeacetylasen","authors":"Sabrina Kempe","doi":"10.1007/s15015-024-3737-1","DOIUrl":"https://doi.org/10.1007/s15015-024-3737-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"46 6","pages":"40-44"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139686401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Früher Brustkrebs: Deeskalierte Chemotherapie im Vorteil 早期乳腺癌：降级化疗具有优势
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3721-1
T. Müller
{"title":"Früher Brustkrebs: Deeskalierte Chemotherapie im Vorteil","authors":"T. Müller","doi":"10.1007/s15015-023-3721-1","DOIUrl":"https://doi.org/10.1007/s15015-023-3721-1","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"58 23","pages":"29"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139687860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UGN-101 beim Urothelkarzinom retrograd oder antegrad instillieren? UGN-101 在尿路上皮癌中是逆行灌注还是前行灌注？
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-024-3728-2
N. Zink
{"title":"UGN-101 beim Urothelkarzinom retrograd oder antegrad instillieren?","authors":"N. Zink","doi":"10.1007/s15015-024-3728-2","DOIUrl":"https://doi.org/10.1007/s15015-024-3728-2","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"637 ","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140466106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Wann aus dem Barrett-Ösophagus ein Adenokarzinom wird 当巴雷特食道变为腺癌时
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3706-0
T. Müller
{"title":"Wann aus dem Barrett-Ösophagus ein Adenokarzinom wird","authors":"T. Müller","doi":"10.1007/s15015-023-3706-0","DOIUrl":"https://doi.org/10.1007/s15015-023-3706-0","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"19 10","pages":"14"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139684642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HCC: PD1-Hemmer Tislelizumab bewährt sich in der Erstlinie HCC：PD1抑制剂tislelizumab证明了其在一线治疗中的价值
Im Fokus Onkologie
Pub Date : 2024-02-01 DOI: 10.1007/s15015-023-3716-y
T. Müller
{"title":"HCC: PD1-Hemmer Tislelizumab bewährt sich in der Erstlinie","authors":"T. Müller","doi":"10.1007/s15015-023-3716-y","DOIUrl":"https://doi.org/10.1007/s15015-023-3716-y","url":null,"abstract":"","PeriodicalId":13436,"journal":{"name":"Im Fokus Onkologie","volume":"4 6","pages":"12"},"PeriodicalIF":0.0,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139684767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
类型
全部 化学•材料 生命科学 医学 物理 工程技术 环境•农林 材料科学 地球科学 法学 管理学 化学 环境科学与生态学 计算机科学 教育学 经济学 农林科学 人文科学 生物学 数学 物理与天体物理 心理学 综合性期刊 其他 工业工程 理学 历史学 农学 文学 信息工程
数据库
全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley
期刊
Im Fokus Onkologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
﹀
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们：info@booksci.cn
Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1